. Author manuscript; available in PMC: 2021 Jul 1.

Published in final edited form as: Eur J Endocrinol. 2020 Jul;183(1):63–71. doi: 10.1530/EJE-20-0129

Table 1.

Demographic and clinical characteristics of study participants

		Controls	N21OHD	p
n		54	32
Age (years)		27 (6–70)	25 (6–66)	0.223
Sex (F/M)		47/7	25/7	0.367
BMI (kg/m²)		27.9 [23.3–32.9]	25.1 [20.6–29.7]	0.085
Diagnosis (n)
	PCOS	27
	Hirsutism	9
	Menstrual dysfunction	3
	Precocious pubarche	5
	Suspicion for AI	4
	Short stature	1
	Early onset alopecia	1
	Suspicion for CAH^*	4

Data are expressed as medians and range for age, and interquartile range for BMI.

Patients referred from outside for cosyntropin stimulation with the suspicion of congenital adrenal hyperplasia (CAH), without other clinical details available.

N21OHD, nonclassic 21-hydroxylase deficiency; PCOS, polycystic ovary syndrome; AI, adrenal insufficiency; F, females; M, males.